KLRG1 and Ebola hemorrhagic fever: Importantly, a recent study found that the expansion of CD57+KLRG1+ T cells in CMV+ young adults is associated with a reduced Ebola vaccine response (Bowyer et al., 2020), suggesting that CMV infection could also have negative impacts on vaccination efficacy.